Robots Are Coming to the Cath Lab
About this episode
This episode explores the future of interventional cardiology through robotic precision with Dr. Philippe Bencteux of RoboCath.
What if the future of interventional cardiology isn't just better devices—but robotic precision? In this episode of Med Tech Gurus, we sit down with Dr. Philippe Bencteux, founder and president of RoboCath, a pioneering company developing robotic platforms designed to transform cardiovascular and neurovascular interventions. A neuroradiologist turned entrepreneur, Dr. Bencteux launched RoboCath after witnessing how access to specialized vascular expertise can determine whether patients live or die—particularly in hospitals lacking advanced interventional capabilities. His vision: bring robotic precision and eventually remote care to life-saving endovascular procedures. We explore the evolution of RoboCath's robotic systems, including the R1 platform, which demonstrated more than 98% technical success in multicenter studies, and the company's next-generation system now entering first-in-human trials for coronary artery disease. Dr. Bencteux shares how robotics can dramatically improve physician safety by reducing radiation exposure and physical strain in the cath lab, while also increasing procedural precision and enabling more complex interventions. If you're interested in…
People in this episode
Host: Tom Hickey
Guest: Dr. Philippe Bencteux
Topics covered
- robotic surgery
- interventional cardiology
- digital health
- AI-driven medical devices
- remote healthcare
Keywords
- robotics
- cardiology
- medical devices
- patient care
- surgery
- healthcare innovation
Mentioned in this episode
Organizations: RoboCath
Products: R1 platform
Places: cardiovascular, neurovascular
More episodes of Med Tech Gurus
- The End of 'See One, Do One, Teach One
- Visibility Is the New Currency
- Why Telehealth Isn't Just a Video Call
- Data Isn't Strategy
Explore listener stats, chart rankings, contacts and more on the Med Tech Gurus podcast page.